arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

OmniAb, Inc.

OABI
$4.79 ▼ -0.12 (-2.55%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
27 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

OmniAb, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $616.9M
Dividend Yield
Revenue Growth 244.2%
Op. Margin -49.5%
ROIC -2.4%
FCF / Share $0.02
Trailing P/E
Price / Book 2.7x
FCF Yield 0.4%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.41M
↑ +244.2%
Net Income Profit after all expenses
$-7.71M
↑ +57.7%
Operating Margin Operating profit as % of sales
-49.5%
↑ +8.8% 0th
FCF / Share Free cash flow per share
$0.02
↑ +150.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
26
Cash Quality
43

Dividend History

Dividend / share · sourced from SEC filings
$2.50 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters